Daniel J. Gennevois
Plus aucun poste en cours
Profil
Daniel J.
Gennevois has been Vice President of Medical Affairs for Anesiva, Inc. since August 2003.
Previously, he was Senior Managing Director of Xoma Corporation from June 2003 to July 2003, Executive Director and Vice President of Clinical Operations for Dynavax Technologies from June 2001 to June 2003, Senior Director of Clinical Research for Roche Bioscience from March 1997 to May 2001, Director of Clinical Research for Chiron Vaccines from November 1995 to March 1997 and Director of Medical Research for Syntex Corporation from June 1991 to November 1995.
From 1985 to 1991, Dr. Gennevois was Associate Director of Clinical and Business Development for American Bioproducts Co. and Scientific Manager for Porton Products.
He received a Bachelor's degree in Mathematics from Lycee Ampere and a Doctor of Medicine degree from the University of Lyon and completed Clinical Training in Infectious Disease at the Hospital Edouard Herriot.
Anciens postes connus de Daniel J. Gennevois
| Sociétés | Poste | Fin |
|---|---|---|
| XOMA CORPORATION | Directeur Technique/Scientifique/R&D | 01/07/2006 |
| DYNAVAX TECHNOLOGIES CORPORATION | Directeur Technique/Scientifique/R&D | 01/06/2003 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Directeur Technique/Scientifique/R&D | 01/05/2001 |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/03/1997 |
| Syntex Corp. | Directeur Technique/Scientifique/R&D | 01/11/1995 |
Formation de Daniel J. Gennevois
| University of Lyon | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| XOMA CORPORATION | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Anesiva, Inc.
 Anesiva, Inc. Pharmaceuticals: MajorHealth Technology Anesiva, Inc. develops and markets therapeutic drugs. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. The firm was founded in 1999 and is headquartered in San Francisco, CA. | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Health Technology |
| Syntex Corp. | Health Technology |